SI1233953T1 - Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same - Google Patents

Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same

Info

Publication number
SI1233953T1
SI1233953T1 SI200030099T SI200030099T SI1233953T1 SI 1233953 T1 SI1233953 T1 SI 1233953T1 SI 200030099 T SI200030099 T SI 200030099T SI 200030099 T SI200030099 T SI 200030099T SI 1233953 T1 SI1233953 T1 SI 1233953T1
Authority
SI
Slovenia
Prior art keywords
preparation
pharmaceutical compositions
sub
compositions containing
containing same
Prior art date
Application number
SI200030099T
Other languages
English (en)
Slovenian (sl)
Inventor
Bernard Pirotte
Tullio Pascal De
Stephane Boverie
Isabelle Kempen
Pierre Lestage
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of SI1233953T1 publication Critical patent/SI1233953T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
SI200030099T 1999-11-30 2000-11-28 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same SI1233953T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9915034A FR2801587B1 (fr) 1999-11-30 1999-11-30 Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP00981466A EP1233953B1 (fr) 1999-11-30 2000-11-28 Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2000/003313 WO2001040210A1 (fr) 1999-11-30 2000-11-28 Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
SI1233953T1 true SI1233953T1 (en) 2003-10-31

Family

ID=9552685

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030099T SI1233953T1 (en) 1999-11-30 2000-11-28 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same

Country Status (24)

Country Link
US (1) US6894043B1 (xx)
EP (1) EP1233953B1 (xx)
JP (1) JP2003515599A (xx)
KR (1) KR100477385B1 (xx)
CN (1) CN1162414C (xx)
AT (1) ATE240306T1 (xx)
AU (1) AU772641B2 (xx)
BR (1) BR0015826A (xx)
CA (1) CA2392929A1 (xx)
DE (1) DE60002755T2 (xx)
DK (1) DK1233953T3 (xx)
EA (1) EA004053B1 (xx)
ES (1) ES2199188T3 (xx)
FR (1) FR2801587B1 (xx)
HK (1) HK1052697B (xx)
HU (1) HUP0204154A3 (xx)
MX (1) MXPA02004593A (xx)
NO (1) NO20022552L (xx)
NZ (1) NZ519271A (xx)
PL (1) PL355722A1 (xx)
PT (1) PT1233953E (xx)
SI (1) SI1233953T1 (xx)
WO (1) WO2001040210A1 (xx)
ZA (1) ZA200203305B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2833950B1 (fr) * 2001-12-21 2005-12-16 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) * 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) * 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DK1781265T3 (da) * 2004-08-25 2010-08-02 Essentialis Inc Farmaceutiske formuleringer af kalium ATP-kanal-åbnere og anvendelser deraf
WO2006034196A1 (en) * 2004-09-17 2006-03-30 Lifelike Biomatic Inc. Compositions for enhancing memory and methods therefor
FR2877338B1 (fr) * 2004-11-03 2007-01-26 Servier Lab Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2877342B1 (fr) * 2004-11-03 2007-01-26 Servier Lab Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP5543110B2 (ja) 2006-01-05 2014-07-09 エッセンシャリス，インク． カリウムａｔｐチャネルオープナの塩およびその使用
KR100787130B1 (ko) * 2006-03-23 2007-12-21 한국화학연구원 신규의 치환된 1,1-다이옥소-벤조[1,2,4]티아디아진-3-온, 이의 제조방법 및 이를 포함하는 약학적 조성물
CA2692160A1 (en) * 2007-07-02 2009-01-08 Essentialis, Inc. Salts of potassium atp channel openers and uses thereof
US20110218190A1 (en) * 2008-11-10 2011-09-08 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
UY33551A (es) 2010-08-10 2012-03-30 Takeda Pharmaceutical Compuesto heterocíclico y su uso
CN102600171A (zh) * 2010-10-27 2012-07-25 北京理工大学 一类苯并噻二嗪和吡啶并噻二嗪衍生物作为醛糖还原酶抑制剂的结构、合成方法及用途
EP3215270B1 (en) * 2014-11-03 2020-05-27 The General Hospital Corporation Concentrating particles in a microfluidic device
CN111518058B (zh) * 2020-05-29 2021-03-09 四川大学华西医院 一种噁噻嗪类化合物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2130096A1 (fr) * 1992-04-15 1993-10-28 Jean-Claude Aloup Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant
FR2690160A1 (fr) * 1992-04-15 1993-10-22 Rhone Poulenc Rorer Sa Application de dérivés d'acide 2H-1,2,4-benzothiadiazine-1,1-dioxyde-3-carboxylique à la préparation de médicaments, les produits nouveaux, leur préparation et les médicaments les contenant.
FR2710062B1 (fr) * 1993-09-17 1995-12-01 Rhone Poulenc Rorer Sa Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant.
WO1998012185A1 (en) * 1996-09-17 1998-03-26 The Regents Of The University Of California Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor

Also Published As

Publication number Publication date
HK1052697B (zh) 2005-02-08
ATE240306T1 (de) 2003-05-15
DE60002755D1 (de) 2003-06-18
CA2392929A1 (fr) 2001-06-07
KR20020058047A (ko) 2002-07-12
DK1233953T3 (da) 2003-08-11
NO20022552D0 (no) 2002-05-29
WO2001040210A1 (fr) 2001-06-07
US6894043B1 (en) 2005-05-17
KR100477385B1 (ko) 2005-03-17
AU772641B2 (en) 2004-05-06
NZ519271A (en) 2004-02-27
NO20022552L (no) 2002-07-11
EA004053B1 (ru) 2003-12-25
PT1233953E (pt) 2003-08-29
EP1233953A1 (fr) 2002-08-28
MXPA02004593A (es) 2002-09-02
CN1162414C (zh) 2004-08-18
PL355722A1 (en) 2004-05-17
JP2003515599A (ja) 2003-05-07
FR2801587A1 (fr) 2001-06-01
FR2801587B1 (fr) 2002-01-11
HUP0204154A2 (hu) 2003-03-28
EP1233953B1 (fr) 2003-05-14
HK1052697A1 (en) 2003-09-26
CN1402717A (zh) 2003-03-12
AU1870401A (en) 2001-06-12
EA200200489A1 (ru) 2002-10-31
ES2199188T3 (es) 2004-02-16
ZA200203305B (en) 2003-06-25
HUP0204154A3 (en) 2006-01-30
BR0015826A (pt) 2002-07-30
DE60002755T2 (de) 2004-04-29

Similar Documents

Publication Publication Date Title
HK1052697A1 (en) Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same.
EP1103552A4 (en) BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
AU1286001A (en) Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
WO2000061568A3 (de) Mit zuckerresten substituierte 1,4-benzothiazepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
AU2337197A (en) Cinnamic acid derivatives and their use as integrin antagonists
AU2420897A (en) Meta-substituted phenylene sulphonamide derivatives
EP1207155A4 (en) DRUG COMPOSITIONS HAVING AGONIST THROMBOPOIETINE ACTIVITY
DK0889875T3 (da) Cycloproylalkansyrederivater
HU9500240D0 (en) New prolin-amide derivatives and pharmaceutical compositions containing them as active component
EP1253142A4 (en) COMPOUNDS HAVING AGONISM AGAINST THE THROMBOPOIETIN RECEPTOR
IE872329L (en) New cephem compounds and processes for preparation thereof
CA2336412A1 (en) Medicament for treatment of diabetes
EP1020452A4 (en) benzimidazole derivatives
IT1271456B (it) Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili, processi di preparazione e composizioni farmaceutiche che li contengono
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
EP1172107A4 (en) MEDICINES CONTAINING SULFOPYRANOSYLACYLGLYCEROL DERIVATIVES
HUP0202438A2 (hu) Dioxo-tiazolidin-származékok és ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
CA2245484A1 (en) Novel urea derivatives
AU2002214056A1 (en) Farnesyl transferase inhibiting benzoheterocyclic derivatives
EP1005334A4 (en) NEUROPROTECTIVE COMPOUNDS AND THEIR APPLICATIONS
DE69024154T2 (de) Pyrimidoindolderivate und Verfahren zu ihrer Herstellung
EP1241166A4 (en) 3-MEHTYL CHROMAN AND THIOCHROME DERIVATIVES
EP1227098A4 (en) TRIAZOLPURINE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THEM AND MEANS THAT SHOW AFFINITY TO THE ADENOSINE A3 RECEPTOR
AU659738B2 (en) New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them